This study investigates the molecular basis of IPF, pinpointing 67 key genes linked to the disease, with a focus on notable genes like ASPN and COL1A1. It also identifies potential therapeutic targets and regulators through protein interactions, microRNAs, and transcription factors. Here, COL1A1 is linked to idiopathic pulmonary fibrosis.